Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016 (2016), Article ID 3219017, 11 pages
http://dx.doi.org/10.1155/2016/3219017
Research Article

Prolactin Rescues Immature B-Cells from Apoptosis Induced by B-Cell Receptor Cross-Linking

1UIM en Inmunología, Hospital de Pediatría, CMN Siglo XXI, IMSS, 06720 Ciudad de México, DF, Mexico
2Programa de Doctorado en Ciencias Biomédicas, UNAM, 04510 Ciudad de México, DF, Mexico
3Hospital Infantil de México Federico Gómez, Unidad de Investigación en Virología y Cáncer, 06720 Ciudad de México, DF, Mexico
4Departamento de Investigación en Bioquímica, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosió Villegas”, 14080 Ciudad de México, DF, Mexico
5Unidad de Investigación y Bioterio, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosió Villegas”, 14080 Ciudad de México, DF, Mexico

Received 26 February 2016; Revised 25 April 2016; Accepted 5 May 2016

Academic Editor: Oscar Bottasso

Copyright © 2016 Rocio Flores-Fernández et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Wahren-Herlenius and T. Dörner, “Immunopathogenic mechanisms of systemic autoimmune disease,” The Lancet, vol. 382, no. 9894, pp. 819–831, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Choi, S. T. Kim, and J. Craft, “The pathogenesis of systemic lupus erythematosus—an update,” Current Opinion in Immunology, vol. 24, no. 6, pp. 651–657, 2012. View at Publisher · View at Google Scholar
  3. S. Yurasov, H. Wardemann, J. Hammersen et al., “Defective B cell tolerance checkpoints in systemic lupus erythematosus,” The Journal of Experimental Medicine, vol. 201, no. 5, pp. 703–711, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. L. Lamoureux, L. C. Watson, M. Cherrier, P. Skog, D. Nemazee, and A. J. Feeney, “Reduced receptor editing in lupus-prone MRL/lpr mice,” The Journal of Experimental Medicine, vol. 204, no. 12, pp. 2853–2864, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Yurasov, T. Tiller, M. Tsuiji et al., “Persistent expression of autoantibodies in SLE patients in remission,” Journal of Experimental Medicine, vol. 203, no. 10, pp. 2255–2261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. P. B. Medeiros, M. V. Febrônio, E. Bonfá, E. F. Borba, A. D. Takiuti, and C. A. A. Silva, “Menstrual and hormonal alterations in juvenile systemic lupus erythematosus,” Lupus, vol. 18, no. 1, pp. 38–43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Doria, M. Cutolo, A. Ghirardello et al., “Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus,” Arthritis Care and Research, vol. 47, no. 2, pp. 202–209, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Yang, Q. Li, X. Yang, and M. Li, “Increased serum level of prolactin is related to autoantibody production in systemic lupus erythematosus,” Lupus, vol. 25, no. 5, pp. 513–519, 2016. View at Publisher · View at Google Scholar
  9. F. Blanco-Favela, G. Quintal-Alvarez, and A. Leaños-Miranda, “Association between prolactin and disease activity in systemic lupus erythematosus. Influence of statistical power,” Journal of Rheumatology, vol. 26, no. 1, pp. 55–59, 1999. View at Google Scholar · View at Scopus
  10. X. Zhu, J. Xu, S. Li, W. Huang, and F. Li, “Role of abnormal anterior pituitary hormones-growth hormone and prolactin in active systemic lupus erythematosus,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 10, pp. 19223–19231, 2015. View at Google Scholar
  11. M. F. Ugarte-Gil, R. V. Gamboa-Cárdenas, F. Zevallos et al., “High prolactin levels are independently associated with damage accrual in systemic lupus erythematosus patients,” Lupus, vol. 23, no. 10, pp. 969–974, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Karimifar, A. Tahmasebi, Z. S. Bonakdar, and S. Purajam, “Correlation of serum prolactin levels and disease activity in systematic lupus erythematosus,” Rheumatology International, vol. 33, no. 2, pp. 511–516, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. R. McMurray, D. Keisler, K. Kanuckel, S. Izui, and S. E. Walker, “Prolactin influences autoimmune disease activity in the female B/W mouse,” Journal of Immunology, vol. 147, no. 11, pp. 3780–3787, 1991. View at Google Scholar · View at Scopus
  14. Y. Ledesma, F. Blanco, E. Fuentes et al., “Higher levels of PRL receptor in Transitional 1 B cells correlates with increased numbers of this population after PRL treatment and an early onset of lupus symptoms,” BMC Immunology, vol. 13, article 11, 2012. View at Google Scholar
  15. M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy, “Prolactin: structure, function, and regulation of secretion,” Physiological Reviews, vol. 80, no. 4, pp. 1523–1631, 2000. View at Google Scholar · View at Scopus
  16. V. Bernard, J. Young, P. Chanson, and N. Binart, “New insights in prolactin: pathological implications,” Nature Reviews Endocrinology, vol. 11, no. 5, pp. 265–275, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Binart, A. Bachelot, and J. Bouilly, “Impact of prolactin receptor isoforms on reproduction,” Trends in Endocrinology and Metabolism, vol. 21, no. 6, pp. 362–368, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Tomio, D. J. Schust, K. Kawana et al., “Prolactin can modulate CD4+ T-cell response through receptor-mediated alterations in the expression of T-bet,” Immunology and Cell Biology, vol. 86, no. 7, pp. 616–621, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. G. López-Rincón, R. Mancilla, A. L. Pereira-Suárez et al., “Expression of autocrine prolactin and the short isoform of prolactin receptor are associated with inflammatory response and apoptosis in monocytes stimulated with Mycobacterium bovis proteins,” Experimental and Molecular Pathology, vol. 98, no. 3, pp. 517–526, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. M. V. Legorreta-Haquet, K. Chávez-Rueda, E. Montoya-Díaz et al., “Prolactin down-regulates CD4+CD25hiCD127low/ regulatory T cell function in humans,” Journal of Molecular Endocrinology, vol. 48, pp. 77–85, 2012. View at Publisher · View at Google Scholar
  21. K. Chavez-Rueda, J. Hérnández, E. Zenteno, A. Leaños-Miranda, M. V. Legorreta-Haquet, and F. Blanco-Favela, “Identification of prolactin as a novel immunomodulator on the expression of co-stimulatory molecules and cytokine secretions on T and B human lymphocytes,” Clinical Immunology, vol. 116, no. 2, pp. 182–191, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Sodhi and A. Tripathi, “Prolactin and growth hormone induce differential cytokine and chemokine profile in murine peritoneal macrophages in vitro: involvement of p-38 MAP kinase, STAT3 and NF-κB,” Cytokine, vol. 41, no. 2, pp. 162–173, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. V. Legorreta-Haquet, R. Flores-Fernández, F. Blanco-Favela et al., “Prolactin levels correlate with abnormal B cell maturation in MRL and MRL/lpr mouse models of systemic lupus erythematosus-like disease,” Clinical and Developmental Immunology, vol. 2013, Article ID 287469, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Von Boehmer and F. Melchers, “Checkpoints in lymphocyte development and autoimmune disease,” Nature Immunology, vol. 11, no. 1, pp. 14–20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. D. A. Nemazee and K. Burki, “Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes,” Nature, vol. 337, no. 6207, pp. 562–566, 1989. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Malissein, M. Verdier, M. H. Ratinaud, and D. Troutaud, “Activation of Bad trafficking is involved in the BCR-mediated apoptosis of immature B cells,” Apoptosis, vol. 11, no. 6, pp. 1003–1012, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Kajihara, H. Sakamoto, K. Tanabe et al., “Protein phosphatase 6 controls BCR-induced apoptosis of WEHI-231 cells by regulating ubiquitination of Bcl-xL,” Journal of Immunology, vol. 192, no. 12, pp. 5720–5729, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. L. S. Teodorovic, C. Babolin, S. L. Rowland et al., “Activation of Ras overcomes B-cell tolerance to promote differentiation of autoreactive B cells and production of autoantibodies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 27, pp. E2797–E2806, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Azulay-Debby, E. Edry, and D. Melamed, “CpG DNA stimulates autoreactive immature B cells in the bone marrow,” European Journal of Immunology, vol. 37, no. 6, pp. 1463–1475, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. R. J. Benschop, E. Brandl, A. C. Chan, and J. C. Cambier, “Unique signaling properties, of B cell antigen receptor in mature and immature B cells: implications for tolerance and activation,” The Journal of Immunology, vol. 167, no. 8, pp. 4172–4179, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. D. T. Patton, A. W. Plumb, and N. Abraham, “The survival and differentiation of Pro-B and Pre-B cells in the bone marrow is dependent on IL-7Rα Tyr449,” Journal of Immunology, vol. 193, no. 7, pp. 3446–3455, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Johnson, J. Chaumeil, M. Micsinai et al., “IL-7 functionally segregates the pro-B cell stage by regulating transcription of recombination mediators across cell cycle,” Journal of Immunology, vol. 188, no. 12, pp. 6084–6092, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Reynaud, I. A. Demarco, K. L. Reddy et al., “Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros,” Nature Immunology, vol. 9, no. 8, pp. 927–936, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. H. S. Dengler, G. V. Baracho, S. A. Omori et al., “Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation,” Nature Immunology, vol. 9, no. 12, pp. 1388–1398, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Decker, M. Pasca di Magliano, S. McManus et al., “Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis,” Immunity, vol. 30, no. 4, pp. 508–520, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Bannish, E. M. Fuentes-Pananá, J. C. Cambier, W. S. Pear, and J. G. Monroe, “Ligand-independent signaling functions for the B lymphocyte antigen receptor and their role in positive selection during B lymphopoiesis,” The Journal of Experimental Medicine, vol. 194, no. 11, pp. 1583–1596, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. S. M. Richards, R. D. Garman, L. Keyes, B. Kavanagh, and J. M. McPherson, “Prolactin is an antagonist of TGF-β activity and promotes proliferation of murine B cell hybridomas,” Cellular Immunology, vol. 184, no. 2, pp. 85–91, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Meng, C.-H. Tsai-Morris, and M. L. Dufau, “Human prolactin receptor variants in breast cancer: low ratio of short forms to the long-form human prolactin receptor associated with mammary carcinoma,” Cancer Research, vol. 64, no. 16, pp. 5677–5682, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Yonezawa, K.-H. Chen, M. K. Ghosh et al., “Anti-metastatic outcome of isoform-specific prolactin receptor targeting in breast cancer,” Cancer Letters, vol. 366, no. 1, pp. 84–92, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Van Coppenolle, R. Skryma, H. Ouadid-Ahidouch et al., “Prolactin stimulates cell proliferation through a long form of prolactin receptor and K+ channel activation,” Biochemical Journal, vol. 377, no. 3, pp. 569–578, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Gonzalez, S. Saha, and E. Peeva, “Prolactin rescues and primes autoreactive B cells directly and indirectly through dendritic cells in B6.Sle3 mice,” Clinical and Experimental Immunology, vol. 172, no. 2, pp. 311–320, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. S. K. Kochendoerfer, N. Krishnan, D. J. Buckley, and A. R. Buckley, “Prolactin regulation of Bcl-2 family members: increased expression of bcl-xL but not mcl-1 or bad in Nb2-T cells,” Journal of Endocrinology, vol. 178, no. 2, pp. 265–273, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. M. T. Beck, S. K. Peirce, and W. Y. Chen, “Regulation of bcl-2 gene expression in human breast cancer cells by prolactin and its antagonist, hPRL-G129R,” Oncogene, vol. 21, no. 33, pp. 5047–5055, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Catlett-Falcone, T. H. Landowski, M. M. Oshiro et al., “Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells,” Immunity, vol. 10, no. 1, pp. 105–115, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Socolovsky, A. E. J. Fallon, S. Wang, C. Brugnara, and H. F. Lodish, “Fetal anemia and apoptosis of red cell progenitors in Stat5a–/–5b–/– mice: a direct role for stat5 in Bcl-X(L) induction,” Cell, vol. 98, no. 2, pp. 181–191, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Silva, A. Benito, C. Sanz et al., “Erythropoietin can induce the expression of Bcl-xL through Stat5 in erythropoietin-dependent progenitor cell lines,” The Journal of Biological Chemistry, vol. 274, no. 32, pp. 22165–22169, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. N. Adań, J. Guzmán-Morales, M. G. Ledesma-Colunga et al., “Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis,” The Journal of Clinical Investigation, vol. 123, no. 9, pp. 3902–3913, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Correale, M. F. Farez, and M. C. Ysrraelit, “Role of prolactin in B cell regulation in multiple sclerosis,” Journal of Neuroimmunology, vol. 269, no. 1-2, pp. 76–86, 2014. View at Publisher · View at Google Scholar · View at Scopus